Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-13 4:50 pm Purchase | 13G | NOVELION THERAPEUTICS INC NVLN | Stonepine Capital Management LLC | 3,909,207 19.9% | 205,787 (+5.56%) | View |
| 2020-01-21 2:10 pm Sale | 13G | NOVELION THERAPEUTICS INC NVLN | NB Public Equity K/S | 0 0% | -1,890,525 (Position Closed) | View |
| 2020-01-15 5:11 pm Purchase | 13G | NOVELION THERAPEUTICS INC NVLN | Broadfin Capital LLC | 2,541,222 12.9% | 606,299 (+31.33%) | View |
| 2020-01-10 5:16 pm Purchase | 13G | NOVELION THERAPEUTICS INC NVLN | EdgePoint Investment Group Inc. | 3,674,185 18.73% | 1,044,367 (+39.71%) | View |
| 2019-10-02 5:11 pm Purchase | 13G | NOVELION THERAPEUTICS INC NVLN | Stonepine Capital Management LLC | 3,703,420 18.9% | 2,548,335 (+220.62%) | View |
| 2019-09-27 5:00 pm Sale | 13D | NOVELION THERAPEUTICS INC NVLN | Whitefort Capital Master Fund LP | 286,230 1.5% | -1,600,000 (-84.83%) | View |
| 2019-09-20 12:45 pm Sale | 13D | NOVELION THERAPEUTICS INC NVLN | Healthcare Value Capital LLC | 1,400,000 7.4% | -400,000 (-22.22%) | View |
| 2019-08-23 5:09 pm Purchase | 13G | NOVELION THERAPEUTICS INC NVLN | Stonepine Capital Management LLC | 1,155,085 6.1% | 623,423 (+117.26%) | View |
| 2019-06-20 5:29 pm Unchanged | 13D | NOVELION THERAPEUTICS INC NVLN | Whitefort Capital Master Fund LP | 1,886,230 9.9% | 0 (Unchanged) | View |
| 2019-05-31 4:14 pm Purchase | 13G | NOVELION THERAPEUTICS INC NVLN | JFL Capital Management LLC | 1,144,554 6.01% | 1,144,554 (New Position) | View |
| 2019-05-24 1:58 pm Purchase | 13D | NOVELION THERAPEUTICS INC NVLN | Whitefort Capital Master Fund LP | 1,886,230 9.9% | 303,889 (+19.21%) | View |
| 2019-05-15 4:14 pm Unchanged | 13G | NOVELION THERAPEUTICS INC NVLN | HIGHBRIDGE CAPITAL MANAGEMENT LLC | 946,842 4.97% | 0 (Unchanged) | View |